783 URINARY PROSTAGLANDIN E2 LEVELS ARE ELEVATED IN PATIENTS WITH OVERACTIVE BLADDER AND PAINFUL BLADDER SYNDROME AND CORRELATE WITH BLADDER DIARY SYMPTOMS
Paul Abrams(Southmead Hospital), Steve Deacon(Ono Pharmaceutical (United Kingdom)), Takahiro Masuda(Jichi Medical University), Séverine Vincent, M. De Maria, F. Haab, T. Kuwayama(Ono Pharmaceutical (United Kingdom)), G. Amarenco(Sorbonne Université)
Cited by 1
Related Papers
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
|American Journal of Physiology-Renal Physiology|2013|481
Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia
|American Journal of Physiology-Renal Physiology|2013|308
Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice
|American Journal of Physiology-Renal Physiology|2012|158
Osmotic diuresis by SGLT2 inhibition stimulates vasopressin‐induced water reabsorption to maintain body fluid volume
|Physiological Reports|2020|135
Transcutaneous Electrical Tibial Nerve Stimulation in the Treatment of Fecal Incontinence: A Randomized Trial (Consort 1a)
|The American Journal of Gastroenterology|2012|104